NEW YORK (360Dx) – Diagnostics firm Novacyt today announced it has raised €9.7 million ($11.4 million).

The company raised €4.7 million through a conditional placement of almost 7.1 million shares, and €5.0 million through an unconditional direct subscription of nearly 7.7 million shares. Both had an issue price of 59.38 pence per share.

New UK institutional investors and new and current French institutional investors participated in the raise, Novacyt said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.